Neuropathic pain post-COVID-19: a case report.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
22 Jul 2021
Historique:
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 28 7 2021
Statut: epublish

Résumé

A 61-year-old man with no significant medical history developed fever, headache and mild shortness of breath. He tested positive for SARS-CoV-2 and self-isolated at home, not requiring hospital admission. One week after testing positive, he developed acute severe burning pain affecting his whole body, subsequently localised distally in the limbs. There was no ataxia or autonomic failure. Neurological examination was unremarkable. Electrophysiological tests were unremarkable. Skin biopsy, lumbar puncture, enhanced MRI of the brachial plexus and MRI of the neuroaxis were normal. His pain was inadequately controlled with pregabalin but improved while on a weaning regimen of steroids. This case highlights the variety of possible symptoms associated with SARS-CoV-2 infection.

Identifiants

pubmed: 34301704
pii: 14/7/e243459
doi: 10.1136/bcr-2021-243459
pmc: PMC8728379
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):177-188
pubmed: 30224548
Pain Rep. 2021 Jan 27;6(1):e884
pubmed: 33537521
Neurohospitalist. 2014 Oct;4(4):230-40
pubmed: 25360209
J Neurovirol. 2020 Oct;26(5):800-801
pubmed: 32779108
Neurology. 2020 Sep 29;95(13):559-560
pubmed: 32788251
N Engl J Med. 2020 Jun 25;382(26):2574-2576
pubmed: 32302082
Muscle Nerve. 2002 Aug;26(2):173-88
pubmed: 12210380
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Neurol Neuroimmunol Neuroinflamm. 2020 Jun 9;7(5):
pubmed: 32518172
Neurology. 2020 Aug 4;95(5):e601-e605
pubmed: 32303650
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
Lancet Neurol. 2020 May;19(5):383-384
pubmed: 32246917

Auteurs

Matthew McWilliam (M)

Neurology, Kent and Canterbury Hospital, Canterbury, UK.

Michael Samuel (M)

Neurology, William Harvey Hospital, Ashford, UK.
Neurology, King's College London, London, UK.

Fadi Hasan Alkufri (FH)

Neurology, Kent and Canterbury Hospital, Canterbury, UK fadi.alkufri@nhs.net.
Neurology, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH